Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $74.65 USD
Change Today -0.04 / -0.05%
Volume 309.9K
KYTH On Other Exchanges
Symbol
Exchange
Frankfurt
As of 3:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jay Edward Birnbaum Ph.D.

AgeTotal Calculated CompensationThis person is connected to 45 board members in 5 different organizations across 8 different industries.

See Board Relationships
70$114,309

Background*

Dr. Jay Edward Birnbaum, PhD, serves as a dermatology consultant specializing in ethical and OTC drugs, medical devices, and cosmeceuticals. Dr. Birnbaum Co-Founded Kythera Biopharmaceuticals and served its Chief Medical Officer. Dr. Birnbaum has 35 years of industry experience span the areas of discovery research, formulations, clinical R&D, regulatory and marketing, and he has been involved in the development and commercialization of numerous drug and consumer products ...

Read Full Background

Corporate Headquarters*

30930 Russell Ranch Road
Westlake Village, California 91362

United States

Phone: 818-587-4500
Fax: --

Board Members Memberships*

Independent Director
2007-Present
Director and Member of Audit Committee

Education*

PhD
University of Wisconsin - Madison
BS
Trinity College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$73,750
Total Calculated Compensation$114,309
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KYTH:US $74.65 USD -0.04

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Peter J. Arduini Chief Executive Officer, President, Director and Member of Special Award Committee
Integra LifeSciences Holdings Corporation
$827.8K
Olivier Bohuon Chief Executive Officer, Director, Chairman of Disclosures Committee, Chairman of Executive Risk Committee and Member of Nomination & Governance Committee
Smith & Nephew plc
$3.2M
Scott P. Anderson Chairman, Chief Executive Officer and President
Patterson Companies, Inc.
$619.4K
Stanley M. Bergman Executive Chairman and Chief Executive Officer
Henry Schein, Inc.
$1.3M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
¥182.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KYTHERA BIOPHARMACEUTICALS I, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.